Exagen
Develops AVISE tests for diagnosis and monitoring of autoimmune disease.
$7.39
After-hours close+0.01 (+0.14%)
At close$7.38(−1.86%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.19 | — | — |
| Aug 2026 | −$0.19 | −$0.13 | +32.1% |
| May 2026 | −$0.24 | −$0.17 | +29.2% |
| Mar 2026 | −$0.20 | −$0.20 | 0.0% |
| Nov 2025 | −$0.13 | −$0.19 | −46.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Mar 2015 | |||
| Dec 2014 | |||
| Sep 2014 | |||
| Jun 2014 | |||
| Mar 2014 | |||
| Dec 2013 | |||
| Sep 2013 | |||
| Jun 2013 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.19 | — | — | $18.3M | — | — |
| Aug 4, 2026 | −$0.19 | −$0.13 | +32.1% | $17.8M | $19.9M | +12.0% |
| May 11, 2026 | −$0.24 | −$0.17 | +29.2% | $16.4M | $17.3M | +5.5% |
| Mar 10, 2026 | −$0.20 | −$0.20 | 0.0% | $16.6M | $16.6M | +0.4% |
| Nov 4, 2025 | −$0.13 | −$0.19 | −46.2% | $16.5M | $17.2M | +4.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 29, 2025 | ||||||
| May 5, 2025 | ||||||
| Mar 11, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 5, 2024 | ||||||
| May 13, 2024 | ||||||
| Mar 18, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 20, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 22, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 11, 2021 | ||||||
| Mar 16, 2021 | ||||||
| Nov 10, 2020 | ||||||
| Jul 28, 2020 | ||||||
| May 11, 2020 | ||||||
| Mar 25, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Sep 20, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||
| Mar 31, 2015 | ||||||
| Dec 31, 2014 | ||||||
| Sep 30, 2014 | ||||||
| Jun 30, 2014 | ||||||
| Mar 31, 2014 | ||||||
| Dec 31, 2013 | ||||||
| Sep 30, 2013 | ||||||
| Jun 30, 2013 | ||||||